Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rebecca Korn"'
Autor:
Dirk Schnappinger, Rebecca E Audette, Kristine M. Guinn, Michael Fitzgerald, Michelle Gardner, Carolina Trujillo, Joshua Davis, Joshua B. Wallach, Jessica T. Pinkham, Deborah T. Hung, Nirmalya Bandyopadhyay, Mary Stanley, Natalia Betancourt, Christina Gallo, Megan K. Proulx, Jennifer A McConnell, Christopher M. Sassetti, Sofia Kennedy, Elisabeth Meyer, James Gomez, Kayla Delano, Paula A Pino, Emily LaVerriere, K. G. Papavinasasundaram, Eric S. Lander, Eric J. Rubin, Michael H Serrano-Wu, Emma Office, Caitlin E Moss, Naomi Song, Nadine Ruecker, Thomas R. Ioerger, Israel Da Silva, Matthew Thompson, Christopher Watson, Sabine Ehrt, Shoko Wakabayashi, Brian K. Hubbard, Tomohiko Kawate, Kenan C. Murphy, Rebecca Korn, Raymond M. Nietupski, Eachan O. D. Johnson, Aaron Golas
Publikováno v:
Nature. 571:72-78
New antibiotics are needed to combat rising levels of resistance, with new Mycobacterium tuberculosis (Mtb) drugs having the highest priority. However, conventional whole-cell and biochemical antibiotic screens have failed. Here we develop a strategy
Autor:
Mary Stanley, Joshua B. Wallach, Michael H Serrano-Wu, Eachan O. D. Johnson, Paula A Pino, Aaron Golas, Rebecca Korn, Naomi Song, Caitlin E Moss, Eric S. Lander, Jessica T. Pinkham, Joshua Davis, Nadine Ruecker, Dirk Schnappinger, Christina Gallo, Tomohiko Kawate, Nirmalya Bandyopadhyay, Deborah T. Hung, Elisabeth Meyer, Michelle Gardner, Jennifer A McConnell, Thomas R. Ioerger, Carolina Trujillo, Megan K. Proulx, Israel Da Silva, Michael Fitzgerald, Kayla Delano, Emma Office, Kristine M. Guinn, Rebecca E Audette, Christopher Watson, K. G. Papavinasasundaram, Eric J. Rubin, Christopher M. Sassetti, Emily LaVerriere, Brian K. Hubbard, Ray Nietupski, Kenan C. Murphy, James Gomez, Matthew Thompson, Sabine Ehrt, Shoko Wakabayashi, Natalia Betancourt
New antibiotics are needed to combat rising resistance, with new Mycobacterium tuberculosis (Mtb) drugs of highest priority. Conventional whole-cell and biochemical antibiotic screens have failed. We developed a novel strategy termed PROSPECT (PRimar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae1a1b6871077bae65e4d61671b2b402
Autor:
Rebecca Körner, Klaus-Dieter Preuss, Natalie Fadle, Darius Madjidi, Frank Neumann, Lennart Bergeler, Stefan Gräber, Cornelia S L Müller, Frank Grünhage, Michael Pfreundschuh, Frank Lammert, Thomas Vogt, Claudia Pföhler
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58087 (2013)
BACKGROUND: Autoantibodies against CD28 have been found in patients with autoimmune and atopic diseases. These antibodies may act as superagonists and activate T cells but may also be antagonistic or induce immunosuppressive effects by activating reg
Externí odkaz:
https://doaj.org/article/a9ca8d9785de429ba14822cdf238bfc8